Trial Outcomes & Findings for Effects of a Wearable Device and Social Media-Based Intervention on Physical Activity and Sleep Quality in Adults (NCT NCT06739876)
NCT ID: NCT06739876
Last Updated: 2026-04-29
Results Overview
Change in physical activity will be assessed by self-report measure on sedentary breaks and behaviour (the measure was developed by the investigator in a previous study). In addition, it will also be assessed by a measurable device (physical activity-related parameters assessed by Garmin monitor).
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
75 participants
Primary outcome timeframe
Baseline, and post-assessment (immediately after the intervention), one month follow-up
Results posted on
2026-04-29
Participant Flow
Participants were recruited using a convenience sampling approach from students and staff aged 18 years or older at National Chung Hsing University through campus announcements and study advertisements.
Eligible participants provided informed consent prior to participation. Baseline information, including demographic characteristics, physical activity levels, and sleep quality measures, was collected before group assignment. Participants were then assigned to the intervention or control group according to the study design.
Participant milestones
| Measure |
No Wearable Device: Control
The control group will not wear the device at times other than completing assessments at baseline, post-intervention, and follow-up.
|
Intervention: Device and Motivational Support Via Social Media
Participants in the Device and motivational support group will wear the device (Garmin tracker) for a month. In addition, they will receive motivational support via social media.
|
Intervention: Device
Participants in the Device group will wear the device (Garmin tracker) for a month.
|
|---|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
Baseline characteristics by cohort
| Measure |
No Wearable Device: Control
n=25 Participants
The control group will not wear the device at times other than completing assessments at baseline, post-intervention, and follow-up.
|
Intervention: Device and Motivational Support Via Social Media
n=25 Participants
Participants in the Device and motivational support group will wear the device (Garmin tracker) for a month. In addition, they will receive motivational support via social media.
|
Intervention: Device
n=25 Participants
Participants in the Device group will wear the device (Garmin tracker) for a month.
|
Total
n=75 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
26.76 Years
STANDARD_DEVIATION 8.34 • n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
24.6 Years
STANDARD_DEVIATION 6.12 • n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
25 Years
STANDARD_DEVIATION 7.91 • n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
25.45 Years
STANDARD_DEVIATION 7.53 • n=75 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
|
Sex: Female, Male
Female
|
13 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
15 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
11 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
39 Participants
n=75 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
|
Sex: Female, Male
Male
|
12 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
10 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
14 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
36 Participants
n=75 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Taiwan
|
25 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
25 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
25 Participants
n=25 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
75 Participants
n=75 Participants • The analysis population includes all 75 participants who were randomized into the three study arms (Arm 1, Arm 2, and Arm 3) at baseline. An Intention-to-Treat (ITT) approach was employed, ensuring that all randomized individuals were accounted for in the primary and secondary outcome evaluations to minimize bias.
|
|
Baseline Measurements of Participants
|
11.71 hours / day
STANDARD_DEVIATION 4.03 • n=25 Participants • This baseline measurement represents the average daily sedentary time, measured in hours, using a Garmin wearable device over a 1-week pre-intervention assessment period. All 75 randomized participants across the three study arms were included to establish initial sedentary behavior levels.
|
12.34 hours / day
STANDARD_DEVIATION 2.87 • n=25 Participants • This baseline measurement represents the average daily sedentary time, measured in hours, using a Garmin wearable device over a 1-week pre-intervention assessment period. All 75 randomized participants across the three study arms were included to establish initial sedentary behavior levels.
|
12.08 hours / day
STANDARD_DEVIATION 3.33 • n=25 Participants • This baseline measurement represents the average daily sedentary time, measured in hours, using a Garmin wearable device over a 1-week pre-intervention assessment period. All 75 randomized participants across the three study arms were included to establish initial sedentary behavior levels.
|
12.04 hours / day
STANDARD_DEVIATION 3.41 • n=75 Participants • This baseline measurement represents the average daily sedentary time, measured in hours, using a Garmin wearable device over a 1-week pre-intervention assessment period. All 75 randomized participants across the three study arms were included to establish initial sedentary behavior levels.
|
PRIMARY outcome
Timeframe: Baseline, and post-assessment (immediately after the intervention), one month follow-upPopulation: All enrolled participants were included in the analysis.
Change in physical activity will be assessed by self-report measure on sedentary breaks and behaviour (the measure was developed by the investigator in a previous study). In addition, it will also be assessed by a measurable device (physical activity-related parameters assessed by Garmin monitor).
Outcome measures
| Measure |
No Wearable Device: Control
n=25 Participants
The control group will not wear the device at times other than completing assessments at baseline, post-intervention, and follow-up.
|
Intervention: Device and Motivational Support Via Social Media
n=25 Participants
Participants in the Device and motivational support group will wear the device (Garmin tracker) for a month. In addition, they will receive motivational support via social media.
|
Intervention: Device
n=25 Participants
Participants in the Device group will wear the device (Garmin tracker) for a month.
|
|---|---|---|---|
|
Changes in Physical Activity
|
8417.24 steps/day
Standard Deviation 4251.32
|
8095.52 steps/day
Standard Deviation 2788.62
|
9497.97 steps/day
Standard Deviation 2708.41
|
SECONDARY outcome
Timeframe: Baseline, and post-assessment (immediately after the intervention), one month follow-upPopulation: Sedentary behavior was assessed using a self-reported questionnaire. The outcome represents the average sedentary time per day (hours / day) reported by participants.
All participants randomized to each group with available sedentary behavior questionnaire data were included in this analysis.
Outcome measures
| Measure |
No Wearable Device: Control
n=25 Participants
The control group will not wear the device at times other than completing assessments at baseline, post-intervention, and follow-up.
|
Intervention: Device and Motivational Support Via Social Media
n=25 Participants
Participants in the Device and motivational support group will wear the device (Garmin tracker) for a month. In addition, they will receive motivational support via social media.
|
Intervention: Device
n=25 Participants
Participants in the Device group will wear the device (Garmin tracker) for a month.
|
|---|---|---|---|
|
Changes in Sedentary Behavior
|
11.71 hours / day
Standard Deviation 4.03
|
12.34 hours / day
Standard Deviation 2.87
|
12.08 hours / day
Standard Deviation 3.33
|
Adverse Events
No Wearable Device: Control
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Intervention: Device and Motivational Support Via Social Media
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Intervention: Device
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place